Friday, October 23, 2026

HomeGeneral NewsCSL in $757m deal with pioneering Dutch biotech

CSL in $757m deal with pioneering Dutch biotech

- Advertisement -


CSL will make an upfront payment of $US117 million for the right to buy privately held VarmX BV. (James Ross/AAP PHOTOS)

By Derek Rose in Sydney

Australian haematology giant CSL has made a deal to potentially acquire a Dutch biotech company researching a breakthrough treatment for a…



Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed